Gonal-f RFF Redi-ject (EMD Serono, Inc.)


Welcome to the PulseAid listing for the Gonal-f RFF Redi-ject drug offered from EMD Serono, Inc.. This Gonadotropin [EPC],Gonadotropins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: EMD Serono, Inc.
NON-PROPRIETARY NAME: FOLLITROPIN
SUBSTANCE NAME: FOLLITROPIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Gonadotropin [EPC],Gonadotropins [Chemical/Ingredient]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-10-16
END MARKETING DATE: 0000-00-00


Gonal-f RFF Redi-ject HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGonal-f RFF Redi-ject from EMD Serono, Inc.
LABELER NAME: EMD Serono, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 300([iU]/.5mL)
START MARKETING DATE: 2013-10-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44087-1115_93e07c94-7f02-4e36-a467-16909551f534
PRODUCT NDC: 44087-1115
APPLICATION NUMBER: NDA021684

Other FOLLITROPIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
EMD Serono, Inc.Gonal-f RFF Pen
Organon USA Inc.Follistim AQ